Literature DB >> 19505190

Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology.

Rüdiger Kaspera1, Rheem A Totah.   

Abstract

BACKGROUND: CYP enzymes from the CYP2C and CYP2J subfamilies metabolize arachidonic acid in a regiospecific and stereoselective manner to eight epoxyeicosatrienoic acids (EETs). Various EETs have been detected in the liver, as well as in many extrahepatic tissues, and have been implicated in numerous physiological functions from cell signaling to vasodilation and angiogenesis.
OBJECTIVE: This report reviews the sites of expression and activity of arachidonic acid epoxygenase CYP isoforms, as well as the physiological role and metabolism of EETs in various extrahepatic tissues. Possible functions of EETs in tissue pathophysiology and implications as potential drug targets are also discussed.
METHODS: The most recent primary research literature on EET forming enzymes and the new physiological functions of EETs in various tissues were reviewed. RESULTS/
CONCLUSIONS: Epoxyeicosatrienoic acids are important in maintaining the homeostasis and in responding to stress in various extra hepatic tissues. It is not clear whether these effects are owing to EETs acting on a universal receptor or through a mechanism involving a second messenger. A better understanding of the regulation of EET levels and their mechanism of action on various receptors will accelerate research aiming at developing therapeutic agents that target EET formation or metabolism pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505190     DOI: 10.1517/17425250902932923

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  31 in total

1.  Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury.

Authors:  S N Batchu; S B Lee; R S Qadhi; K R Chaudhary; H El-Sikhry; R Kodela; J R Falck; J M Seubert
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 2.  EET signaling in cancer.

Authors:  Dipak Panigrahy; Emily R Greene; Ambra Pozzi; Dao Wen Wang; Darryl C Zeldin
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  Analysis of epoxyeicosatrienoic acids by chiral liquid chromatography/electron capture atmospheric pressure chemical ionization mass spectrometry using [13C]-analog internal standards.

Authors:  Clementina Mesaros; Seon Hwa Lee; Ian A Blair
Journal:  Rapid Commun Mass Spectrom       Date:  2010-11-30       Impact factor: 2.419

4.  Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo.

Authors:  Theresa Aliwarga; Brianne S Raccor; Rozenn N Lemaitre; Nona Sotoodehnia; Sina A Gharib; Libin Xu; Rheem A Totah
Journal:  Free Radic Biol Med       Date:  2017-07-19       Impact factor: 7.376

5.  Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.

Authors:  Rüdiger Kaspera; Suresh B Naraharisetti; Eric A Evangelista; Kristin D Marciante; Bruce M Psaty; Rheem A Totah
Journal:  Biochem Pharmacol       Date:  2011-06-24       Impact factor: 5.858

Review 6.  Regulation of inflammation in cancer by eicosanoids.

Authors:  Emily R Greene; Sui Huang; Charles N Serhan; Dipak Panigrahy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-16       Impact factor: 3.072

7.  The nuclear receptors constitutive active/androstane receptor and pregnane x receptor activate the Cyp2c55 gene in mouse liver.

Authors:  Yoshihiro Konno; Hiroki Kamino; Rick Moore; Fred Lih; Kenneth B Tomer; Darryl C Zeldin; Joyce A Goldstein; Masahiko Negishi
Journal:  Drug Metab Dispos       Date:  2010-04-06       Impact factor: 3.922

Review 8.  Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.

Authors:  Dipak Panigrahy; Arja Kaipainen; Emily R Greene; Sui Huang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

9.  Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage.

Authors:  Qian Wang; Wei Pang; Zhuan Cui; Junbao Shi; Yan Liu; Bo Liu; Yunfeng Zhou; Youfei Guan; Bruce D Hammock; Yue Wang; Yi Zhu
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-14

Review 10.  CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

Authors:  Katheryne Z Edson; Allan E Rettie
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.